| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment
|
Hoffmann, Julia
|
|
2014
|
104 |
C |
p. 23-33
11 p.
|
artikel
|
| 2 |
A recombinant adenovirus bicistronically expressing porcine interferon-α and interferon-γ enhances antiviral effects against foot-and-mouth disease virus
|
Kim, Su-Mi
|
|
2014
|
104 |
C |
p. 52-58
7 p.
|
artikel
|
| 3 |
Can hepatitis C virus infection be eradicated in people who inject drugs?
|
Grebely, Jason
|
|
2014
|
104 |
C |
p. 62-72
11 p.
|
artikel
|
| 4 |
Coxsackievirus B3 VLPs purified by ion exchange chromatography elicit strong immune responses in mice
|
Koho, Tiia
|
|
2014
|
104 |
C |
p. 93-101
9 p.
|
artikel
|
| 5 |
Efficacy and tolerability after 24weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV–HCV coinfected subjects
|
Genebat, Miguel
|
|
2014
|
104 |
C |
p. 59-61
3 p.
|
artikel
|
| 6 |
Entry inhibitors and future treatment of hepatitis C
|
Fofana, Isabel
|
|
2014
|
104 |
C |
p. 136-142
7 p.
|
artikel
|
| 7 |
Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment
|
Scharton, Dionna
|
|
2014
|
104 |
C |
p. 84-92
9 p.
|
artikel
|
| 8 |
Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection
|
Ogawa, Eiichi
|
|
2014
|
104 |
C |
p. 102-109
8 p.
|
artikel
|
| 9 |
Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice
|
Bian, Chengrong
|
|
2014
|
104 |
C |
p. 110-117
8 p.
|
artikel
|
| 10 |
Inhibition of BmNPV replication in silkworm cells using inducible and regulated artificial microRNA precursors targeting the essential viral gene lef-11
|
Zhang, Jun
|
|
2014
|
104 |
C |
p. 143-152
10 p.
|
artikel
|
| 11 |
Inhibition of hepatitis B virus replication by ligand-mediated activation of RNase L
|
Park, Il-Hyun
|
|
2014
|
104 |
C |
p. 118-127
10 p.
|
artikel
|
| 12 |
Inside Back Cover: Notes to Authors
|
|
|
2014
|
104 |
C |
p. IBC-
1 p.
|
artikel
|
| 13 |
In vitro inhibition of the replication of classical swine fever virus by porcine Mx1 protein
|
He, Dan-ni
|
|
2014
|
104 |
C |
p. 128-135
8 p.
|
artikel
|
| 14 |
Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease
|
Kwon, Young-Man
|
|
2014
|
104 |
C |
p. 1-6
6 p.
|
artikel
|
| 15 |
Molecular modeling and residue interaction network studies on the mechanism of binding and resistance of the HCV NS5B polymerase mutants to VX-222 and ANA598
|
Xue, Weiwei
|
|
2014
|
104 |
C |
p. 40-51
12 p.
|
artikel
|
| 16 |
Murine models of hepatitis C: What can we look forward to?
|
von Schaewen, Markus
|
|
2014
|
104 |
C |
p. 15-22
8 p.
|
artikel
|
| 17 |
Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III
|
Zu, Xiangyang
|
|
2014
|
104 |
C |
p. 7-14
8 p.
|
artikel
|
| 18 |
Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model
|
Smither, Sophie J.
|
|
2014
|
104 |
C |
p. 153-155
3 p.
|
artikel
|
| 19 |
Prelim II: Editorial Board
|
|
|
2014
|
104 |
C |
p. ii-
1 p.
|
artikel
|
| 20 |
Small molecule inhibition of Epstein–Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome
|
Lee, Eun Kyung
|
|
2014
|
104 |
C |
p. 73-83
11 p.
|
artikel
|
| 21 |
What is the future of ribavirin therapy for hepatitis C?
|
Koh, Christopher
|
|
2014
|
104 |
C |
p. 34-39
6 p.
|
artikel
|
| 22 |
Yeast-based assays for the high-throughput screening of inhibitors of coronavirus RNA cap guanine-N7-methyltransferase
|
Sun, Ying
|
|
2014
|
104 |
C |
p. 156-164
9 p.
|
artikel
|
Tijdschrift beschrijving